Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
bifunctional enzyme UDP-Nacetylglucosamine 2-epimerase/N-acetylmannosamine kinase
-
bifunctional UDP-GlcNAc 2-epimerase/ManNAc kinase
-
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
hydrolyzing UDP-GlcNAc 2-epimerase
-
SeMet UDP-GlcNAc 2-epimerase
-
UDP-GlcNAc 2-epimerase/ManNAc kinase
UDP-GlcNAc-2-epimerase/ManAc kinase
UDP-N-acetylglucosamine 2-epimerase
UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
UDP-N-acetylglucosamine 2-epimerase/Nacetylmannosamine kinase
-
UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase
uridine diphosphate-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
-
uridine diphosphate-N-acetylglucosamine-2-epimerase
-
additional information
cf. EC 2.7.1.60
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
-
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
UniProt
GNE
-
-
-
-
neuC
-
-
-
-
siaA
-
-
-
-
UDP-GlcNAc 2-epimerase
-
UDP-GlcNAc 2-epimerase
-
-
UDP-GlcNAc 2-epimerase
-
bifunctional enzyme complex consisting of UDP-N-acetylglucosamine 2-epimerase and and N-acetylmannosamine kinase
UDP-GlcNAc 2-epimerase
-
bifunctional enzyme exhibiting UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activity
UDP-GlcNAc 2-epimerase
-
bifunctional enzyme complex consisting of UDP-N-acetylglucosamine 2-epimerase and and N-acetylmannosamine kinase
-
UDP-GlcNAc 2-epimerase/ManNAc kinase
-
UDP-GlcNAc 2-epimerase/ManNAc kinase
-
UDP-GlcNAc 2-epimerase/ManNAc kinase
-
-
UDP-GlcNAc-2-epimerase/ManAc kinase
-
UDP-GlcNAc-2-epimerase/ManAc kinase
UniProt
UDP-N-acetylglucosamine 2-epimerase
-
-
UDP-N-acetylglucosamine 2-epimerase
-
-
-
UDP-N-acetylglucosamine 2-epimerase
-
-
UDP-N-acetylglucosamine 2-epimerase
-
-
-
UDP-N-acetylglucosamine 2-epimerase
-
-
UDP-N-acetylglucosamine 2-epimerase
-
-
-
UDP-N-acetylglucosamine 2-epimerase
-
UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
-
-
UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
-
UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase
-
-
UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
UDP-N-acetyl-alpha-D-glucosamine + H2O
?
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-alpha-D-mannosamine + UDP
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-D-mannosamine + UDP
UDP-N-alpha-D-acetylglucosamine + H2O
N-acetyl-alpha-D-mannosamine + UDP
additional information
?
-
UDP-N-acetyl-alpha-D-glucosamine + H2O
?
-
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + H2O
?
-
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + H2O
?
-
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-alpha-D-mannosamine + UDP
-
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-alpha-D-mannosamine + UDP
-
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-alpha-D-mannosamine + UDP
-
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-D-mannosamine + UDP
-
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-D-mannosamine + UDP
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-D-mannosamine + UDP
-
-
-
-
?
UDP-N-acetyl-alpha-D-glucosamine + H2O
N-acetyl-D-mannosamine + UDP
-
-
-
?
UDP-N-alpha-D-acetylglucosamine + H2O
N-acetyl-alpha-D-mannosamine + UDP
-
enzyme catalyzes the formation of ManNAc from UDP-GlcNAc via a 2-acetamidoglucal intermediate
-
-
?
UDP-N-alpha-D-acetylglucosamine + H2O
N-acetyl-alpha-D-mannosamine + UDP
-
enzyme catalyzes the formation of ManNAc from UDP-GlcNAc via a 2-acetamidoglucal intermediate
-
-
?
additional information
?
-
-
bifunctional enzyme UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase consisting of an N-terminal epimerase and a C-terminal kinase domain. The epimerase domain converts UDP-GlcNAc to ManNAc and the kinase domain phosphorylates ManNAc to ManNAc-P
-
-
?
additional information
?
-
analysis of interaction between GNE and alpha-actinin 2, overview. Enzyme GNE shows a much higher affinity for alpha-actinin 2 than to alpha-actinin 1, protein-protein interaction, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
malfunction
-
neuC is deleted from the chromosome of EV36, a K-12-K1 hybrid, by allelic exchange. Exogenously added sialic acid restores capsule expression to the deletion strain, confirming that NeuC is necessary for sialic acid synthesis. The NeuC homologue from serotype III Streptococcus agalactiae complements deletion mutant
malfunction
GNE myopathy is autosomal recessive inherited and characterized by adult onset, slowly progressive muscle weakness and atrophy
malfunction
-
hereditary inclusion body myopathy (GNE myopathy) is a neuromuscular disorder due to mutation in key sialic acid biosynthetic enzyme gene, GNE, D176V and V572L. Mutation in GNE affects beta1-integrin-mediated cell adhesion process in GNE mutant cells
malfunction
isozymes hGNE3 and hGNE8 contain a 53-residue N-terminal deletion, epimerase enzymatic activity of isozymes GNE3 and GNE8 is likely absent, because the deleted fragment contains important substrate binding residues in homologous bacterial epimerases. Isozymes hGNE5-hGNE8 have a 53-residue deletion, which was assigned a role in substrate UDP-GlcNAc binding
malfunction
defective GNE inhibition by CMP-Neu5Ac causes cytoplasmic accumulation and increased excretion of free sialic acid. Sialuria is an autosomal dominant disorder which is related to GNE mutation in one of the two arginine residues 263 and 266 (R263L, R266Q or R266W), the mutations in Arg263 and Arg266 can cause sialuria by hindering the enzyme inhibition through CMP-Neu5Ac binding
malfunction
distal myopathy with rimmed vacuoles (DMRV) is an autosomal recessive genetic disease characterized by weakness of the anterior compartment of the lower limbs, sparing the quadriceps muscle, and rimmed vacuoles in muscle biopsies. The disease is caused by a mutation in the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene located on chromosome 9p13.3. We present two cases of Chinese patients with progressive lower extremity weakness, phenotypes, overview
malfunction
hereditary inclusion body myopathy (GNE myopathy) is a neuromuscular disorder due to mutation in key sialic acid biosynthetic enzyme, GNE. The subcellular distribution of recombinant GNE and its mutant shows differential localization in the cell. The enzyme mutation leads to hyposialylation of cell membrane receptor, beta1-integrin. Hyposialylated beta1-integrin localized to internal vesicles that is restored upon supplementation with sialic acid. Fibronectin stimulation causes migration of hyposialylated beta1-integrin to the cell membrane and colocalization with focal adhesion kinase (FAK) leading to increased focal adhesion formation. This further activates FAK and Src, downstream signaling molecules and leads to increased cell adhesion. The mutation in GNE affects beta1-integrin-mediated cell adhesion process in GNE mutant cells. Activation of endoplasmic reticulum stress response due to accumulation of misfolded mutated GNE protein
malfunction
impaired feed-back inhibition of the enzyme by CMP-Neu5Ac to regulate the GNE activity can result in sialuria
malfunction
mutation M743T of enzyme GNE leads to GNE myopathy (i.e. hereditary inclusion body myopathy, HIBM), a unique muscle pathophysiology disorder
malfunction
phenotype-genotype analysis of GNE myopathy index patients of a kohort, overview
malfunction
-
GNE myopathy is autosomal recessive inherited and characterized by adult onset, slowly progressive muscle weakness and atrophy
-
malfunction
-
neuC is deleted from the chromosome of EV36, a K-12-K1 hybrid, by allelic exchange. Exogenously added sialic acid restores capsule expression to the deletion strain, confirming that NeuC is necessary for sialic acid synthesis. The NeuC homologue from serotype III Streptococcus agalactiae complements deletion mutant
-
metabolism
-
key enzyme in the sialic acid biosynthetic pathway
metabolism
the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase, encoded by the GNE gene, catalyzes the first two committed, rate-limiting steps in the biosynthesis of N-acetylneuraminic acid. Two distinct human disorders, sialuria and hereditary inclusion body myopathy, are associated with predominantly missense mutations in GNE
metabolism
bifunctional UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase, GNE, is key sialic acid biosynthetic enzyme
metabolism
sialic acid biosynthesis in mammals starts by converting UDP-GluNAc into UDP and ManNAc, followed by phosphorylation of ManNAc at the sixth position, catalysis of both reactions is carried out by the bifunctional enzyme GNE. Regulation of cell-surface sialyation level by binding to the downstream product CMP-Neu5Ac. The feedback inhibition is highly positively cooperative and it does not affect the ManNAc kinase activity
metabolism
the biosynthesis of sialic acids starts with hydrolytic epimerization of N-acetyl glucosamine (GlcNAc), catalyzed by UDP-GlcNAc 2-epimerase and producing N-acetyl mannosamine (ManNAc), which then reacts with phosphoenolpyruvate to form Neu5Ac. Whereas the substrate for non-hydrolyzing epimerase and hydrolyzing epimerase is the same, in this case, UDP-GlcNAc, the product of the former is UDP-ManNAc, and that of the latter is alpha-ManNAc plus UDP
physiological function
mGne2 encoding transcript may act as a tissue-specific regulator of sialylation
physiological function
-
the enzyme is involved in sialic acid synthesis and other cellular functions, it plays a role in beta1-integrin-mediated cell adhesion, overview
physiological function
UDP-GlcNAc 2-epimerase/ManNAc kinase catalyzes the first two committed steps in sialic acid synthesis. Isozyme hGNE1 is the ubiquitously expressed major isoform, while the isozymes hGNE2-hGNE8 isoforms are differentially expressed and may act as tissue-specific regulators of sialylation
physiological function
biosynthesis of sialic acid is regulated by a 79-kDa bifunctional enzyme UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase (GNE), consisting of N-terminal epimerase and C-terminal kinase domain. The epimerase domain converts UDP-GlcNAc to ManNAc and kinase domain phosphorylates ManNAc to ManNAc phosphate
physiological function
the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) plays a key role in sialic acid production. It is different from the non-hydrolyzing enzymes for bacterial cell wall biosynthesis, and it is feedback inhibited by the downstream product CMP-Neu5Ac. Being a key enzyme that catalyzes the rate-limiting step of sialic acid biosynthesis, GNE plays an important role in regulation of cell-surface sialyation level by binding to the downstream product CMP-Neu5Ac. Regulation of cell-surface sialyation level by binding to the downstream product CMP-Neu5Ac. The feedback inhibition is highly positively cooperative and it does not affect the ManNAc kinase activity. By mediating cell-cell recognition, sialic acids are important in the development of nervous system. Structure and biosynthesis of sialic acid, overview
physiological function
-
mGne2 encoding transcript may act as a tissue-specific regulator of sialylation
-
additional information
in the dimeric state GNE possess only kinase activity, in the hexameric state it displays both the epimerase and kinase activities while no activity is observed when GNE is present as a monomer
additional information
the binding of UDP-GlcNAc to an allosteric site may stabilize the closed, active conformation of the enzyme, whereas the open form seems to be not active. Residue D143 is essential for catalytic activity
additional information
-
the binding of UDP-GlcNAc to an allosteric site may stabilize the closed, active conformation of the enzyme, whereas the open form seems to be not active. Residue D143 is essential for catalytic activity
additional information
the comparison of the UDP-binding modes of the non-hydrolyzing and hydrolyzing UDP-GlcNAc epimerases might explain the mechanistic difference. While the epimerization reactions of both enzymes are similar, Arg113 and Ser302 of GNE are likely involved in product hydrolysis. Full-length modelling suggests a channel for ManNAc trafficking within the bifunctional enzyme, possible epimerase-kinase channel
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
?
-
x * 80000, recombinant wild-type and mutant enzymes, SDS-PAGE
oligomer
x * 79000, SDS-PAGE
dimer
-
dimer
-
2 * 75000, gel filtration
dimer
-
2 * 75000, gel filtration
-
hexamer
-
6 * 75000, gel filtration
hexamer
-
6 * 75000, gel filtration
-
tetramer
-
additional information
isozyme sequence comparisons, secondary structures, and structure modeling, overview. Isozymes hGNE2 and hGNE7 display a 31-residue N-terminal extension compared to isozyme hGNE1, isozymes hGNE3 and hGNE8 contain a 53-residue N-terminal deletion and a 50-residue N-terminal extension compared to hGNE1
additional information
in the dimeric state GNE possess only kinase activity, in the hexameric state it displays both the epimerase and kinase activities while no activity is observed when GNE is present as a monomer
additional information
the epimerase part of the bifunctional UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) folds into two Rossmann-like domains and forms dimers and tetramers
additional information
-
the epimerase part of the bifunctional UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) folds into two Rossmann-like domains and forms dimers and tetramers
additional information
the full-length enzyme can form a dimer or tetramer, depending on the presence of UDP-GlcNAc and CMP-Neu5Ac. GNE forms a closed tetramer in the presence of UDP-GlcNAc and CMP-Neu5Ac. The complex crystal structure of the N-terminal epimerase part of human GNE shows a tetramer in which UDP binds to the active site and CMP-Neu5Ac binds to the dimer-dimer interface. The enzyme is locked in a tightly closed conformation. Each dimer further forms a tetramer with a crystallographic dyad-related dimer
additional information
isozyme Gne2, secondary structure comparison with the human isozyme Gne2, the isozymes differ most in the N-terminal extension of 31 amino acids
additional information
isozyme Gne2, secondary structure comparison with the human isozyme Gne2, the isozymes differ most in the N-terminal extension of 31 amino acids
additional information
isozyme mGne1, secondary structure comparison with the human isozyme hGne1. The four homologous amino acid changes between mGne1 and hGNE1 are all located in the ManNAc kinase activity encoding domain of Gne; N447S and L523M in an alpha-helix domain, and R481Q and I484V in a coil domain, overview
additional information
isozyme mGne1, secondary structure comparison with the human isozyme hGne1. The four homologous amino acid changes between mGne1 and hGNE1 are all located in the ManNAc kinase activity encoding domain of Gne; N447S and L523M in an alpha-helix domain, and R481Q and I484V in a coil domain, overview
additional information
-
isozyme Gne2, secondary structure comparison with the human isozyme Gne2, the isozymes differ most in the N-terminal extension of 31 amino acids
-
additional information
-
isozyme mGne1, secondary structure comparison with the human isozyme hGne1. The four homologous amino acid changes between mGne1 and hGNE1 are all located in the ManNAc kinase activity encoding domain of Gne; N447S and L523M in an alpha-helix domain, and R481Q and I484V in a coil domain, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
A287V
naturally occuring mutation, pathogenic variant with possible effect on splicing, severe phenotype
C13S
naturally occuring heterozygous missense mutation of a Chinese distal myopathy (DMRV) patient, phenotype, overview. A c.131G->C homozygous missense mutation on exon 3, leading to a C13S amino acid change
C612F
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
C617Y
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
D112A
site-directed mutagenesis, the mutant shows 97.7% reduced activity compared to the wild-type enzyme
D227Y
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
D239E
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, , mild phenotype
D239N
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, mild phenotype
D244V
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, moderate phenotype
D316H
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
E134A
site-directed mutagenesis, inactive mutant
E33G
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, severe phenotype
G237S
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, moderate phenotype
G395R
naturally occuring mutation, pathogenic variant, effect on splicing is uncertain, severe phenotype
G576R
naturally occuring heterozygous missense mutation of a Chinese distal myopathy (DMRV) patient, phenotype, overview. A c.1726G->C heterozygous missense mutation, located on exon 10, resulting in a G576R amino acid change
G590R
naturally occuring mutation, pathogenic variant with possible effect on splicing, severe phenotype
G700R
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, severe phenotype
H179Q
naturally occuring mutation, pathogenic variant with possible effect on splicing, severe phenotype
H251P
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
K406N
naturally occuring mutation, pathogenic variant without effect on splicing, moderate phenotype
L682R
naturally occuring mutation, pathogenic variant without effect on splicing, severe phenotype
M60R
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, severe phenotype
M743T
a naturally occuring GNE myopathy mutant, located at the last exon 13 of the gene
M91V
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, mild phenotype
R113A
site-directed mutagenesis, inactive mutant
R512P
naturally occuring mutation, pathogenic variant without effect on splicing, moderate phenotype
R90X
naturally occuring mutation, pathogenic variant with possible effect on splicing, severe phenotype
S302A
site-directed mutagenesis, the mutant shows 87.1% reduced activity compared to the wild-type enzyme
Y465C
naturally occuring mutation, pathogenic variant with predicted deleterious effects on splicing, moderate phenotype
D100N
-
mutant is found to be significantly catalytically compromised (kcat reduced by 1000)
D131N
-
mutant is found to be significantly catalytically compromised (kcat reduced by 1000), 2-acetamidoglucal is released from the active site during catalysis, providing direct evidence that the enzyme is capable of catalyzing the anti elimination of UDP from UDP-GlcNAc
E122Q
-
mutant is found to be significantly catalytically compromised (kcat reduced by 1000), 2-acetamidoglucal is released from the active site during catalysis, providing direct evidence that the enzyme is capable of catalyzing the anti elimination of UDP from UDP-GlcNAc
D100N
-
mutant is found to be significantly catalytically compromised (kcat reduced by 1000)
-
E122Q
-
mutant is found to be significantly catalytically compromised (kcat reduced by 1000), 2-acetamidoglucal is released from the active site during catalysis, providing direct evidence that the enzyme is capable of catalyzing the anti elimination of UDP from UDP-GlcNAc
-
D143A
site-directed mutagenesis, inactive mutant
D143A
the GNE catalytic site mutant completely loses its activity
D176V
-
naturally occuring mutation involved in hereditary inclusion body myopathy, the mutant enzyme shows 83% reduced UDP-N-acetyl alpha-D-glucosamine epimerase activity compared to the wild-type, N-acetyl mannosamine kinase activity is also reduced but to a lesser extent
D176V
naturally occuring mutation in hereditary inclusion body myopathy (GNE myopathy) patients, phenotype, detailed overview. The mutant enzyme shows 85% reduced activity of the epimerase compared to the wild-type enzyme
V572L
-
naturally occuring mutation involved in hereditary inclusion body myopathy, the mutant enzyme shows 44% reduced UDP-N-acetyl alpha-D-glucosamine epimerase activity compared to the wild-type, N-acetyl mannosamine kinase activity is laos reduced to a higher extent
V572L
naturally occuring mutation in hereditary inclusion body myopathy (GNE myopathy) patients, phenotype, detailed overview. The mutant enzyme shows 44% reduced activity of the epimerase compared to the wild-type enzyme
additional information
-
efficient metabolic oligosaccharide engineering of glycoproteins by GNE enzyme knockdown by specific shRNAs in HEK293 cells. Stable GNE knockout via RNAi dramatically increases incorporation of N-acetylmannosamine analogues into glycoproteins of HEK293 cells. By means of these GNE-deficient cells highly sialylated glycoproteins can efficiently be decorated with reactive functional groups, which can be employed in bioorthogonal functionalization strategies for fluorescence labelling or biotinylation
additional information
-
endogenous GNE is knocked down in HEK-293 cells using GNE-specific shRNA
additional information
endogenous GNE is knocked down from normal HEK cells using shRNA, sialic acid quantitation in GNE overexpressed and knockdown cells, overview. Presence of r-wt-GNE and r-V572L-GNE proteins in nucleus while r-D176V-GNE primarily in the cytoplasm suggesting that mutation in the epimerase domain might prevent nuclear localization of GNE. Activation of endoplasmic reticulum stress response due to accumulation of misfolded mutated GNE protein. Hyposialylation caused due to mutation in GNE is affecting the membrane localization of beta1-integrin
additional information
genotyping of GNE myopathy index patients of a kohort, overview. Functional analysis of possibly abnormal splicing caused by c.717T>G mutation using an in vitro minigene splicing assay. Phenotype modelling
additional information
tissues of the knock-in Gne p.M712T mouse model have similar mGne transcript expression levels among genotypes, indicating no effect of the mutation on mRNA expression
additional information
tissues of the knock-in Gne p.M712T mouse model have similar mGne transcript expression levels among genotypes, indicating no effect of the mutation on mRNA expression
additional information
-
tissues of the knock-in Gne p.M712T mouse model have similar mGne transcript expression levels among genotypes, indicating no effect of the mutation on mRNA expression
-
additional information
selenomethionine-substituted UDP-GlcNAc 2-epimerase is used for crystal structure analysis
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
expressed as a His-tagged fusion protein
-
expressed as a His-tagged fusion protein in Escherichia coli
-
expression of recombinant wild-type and mutant enzymes
-
functionally expressed in Escherichia coli, the yeast strains Saccharomyces cerevisiae and Pichia pastoris, and insect cells. In Escherichia coli, up to 2mg protein/l cell culture is expressed, in yeast cells 0.4mg/l, up to 100 mg/l, are expressed in insect cells. In all three cell systems, insoluble protein aggregates are also observed
-
gene gne, genotyping, transcriptional analysis of the GNE variant c.717T>G, recombinant expression of splicing mutant c.717T>G in HEK 293 cells
gene gne, located on chromosome 9p13.3, genotyping
gene gne, overexpresion of wild-type and mutant enzymes in HEK-293 cells, the endogenous GNE is knocked down in HEK-293 cells using GNE-specific shRNA
gene gne, recombinant expression of N-terminally FLAG3-tagged wild-type and mutant M743T in HEK-293 cells
gene Gne1, sequence comparison with the human isozyme Gne1
gene Gne2, sequence comparison with the human isozyme Gne2
recombinant bifunctional enzyme is expressed in COS7 cells
-
UDP-GlcNAc 2-epimerase/ManNAc kinase from rat is overexpressed in Spodoptera frugiperda cells (Sf9 cells) using a baculovirus expression system
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Stsche, R.; Hinderlich, S.; Weise, C.; Effertz, K.; Lucka, L.; Moormann, P.; Reutter, W.
A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Molecular cloning and functional expression of UDP-N-acetyl-glucosamine 2-epimerase/N-acetylmannosamine kinase
J. Biol. Chem.
272
24319-24324
1997
Rattus norvegicus
brenda
Hinderlich, S.; Stsche, R.; Zeitler, R.; Reutter, W.
A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Purification and characterization of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
J. Biol. Chem.
272
24313-24318
1997
Rattus norvegicus
brenda
Campbell, R.E.; Mosimann, S.C.; Tanner, M.E.; Strynadka, N.C.
The structure of UDP-N-acetylglucosamine 2-epimerase reveals homology to phosphoglycosyl transferases
Biochemistry
39
14993-15001
2000
Streptococcus pneumoniae (P27828)
brenda
Chou, W.K.; Hinderlich, S.; Reutter, W.; Tanner, M.E.
Sialic acid biosynthesis: stereochemistry and mechanism of the reaction catalyzed by the mammalian UDP-N-acetylglucosamine 2-epimerase
J. Am. Chem. Soc.
125
2455-2461
2003
Rattus norvegicus
brenda
Vann, W.F.; Daines, D.A.; Murkin, A.S.; Tanner, M.E.; Chaffin, D.O.; Rubens, C.E.; Vionnet, J.; Silver, R.P.
The NeuC protein of Escherichia coli K1 is a UDP N-acetylglucosamine 2-epimerase
J. Bacteriol.
186
706-712
2004
Escherichia coli
brenda
Murkin, A.S.; Chou, W.K.; Wakarchuk, W.W.; Tanner, M.E.
Identification and mechanism of a bacterial hydrolyzing UDP-N-acetylglucosamine 2-epimerase
Biochemistry
43
14290-14298
2004
Neisseria meningitidis, Neisseria meningitidis MC58 group B
brenda
Blume, A.; Ghaderi, D.; Liebich, V.; Hinderlich, S.; Donner, P.; Reutter, W.; Lucka, L.
UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, functionally expressed in and purified from Escherichia coli, yeast, and insect cells
Protein Expr. Purif.
35
387-396
2004
Rattus norvegicus
brenda
Moeller, H.; Boehrsch, V.; Lucka, L.; Hackenberger, C.P.; Hinderlich, S.
Efficient metabolic oligosaccharide engineering of glycoproteins by UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) knock-down
Mol. Biosyst.
7
2245-2251
2011
Homo sapiens
brenda
Ringenberg, M.A.; Steenbergen, S.M.; Vimr, E.R.
The first committed step in the biosynthesis of sialic acid by Escherichia coli K1 does not involve a phosphorylated N-acetylmannosamine intermediate
Mol. Microbiol.
50
961-975
2003
Escherichia coli
brenda
Yardeni, T.; Choekyi, T.; Jacobs, K.; Ciccone, C.; Patzel, K.; Anikster, Y.; Gahl, W.A.; Kurochkina, N.; Huizing, M.
Identification, tissue distribution, and molecular modeling of novel human isoforms of the key enzyme in sialic acid synthesis, UDP-GlcNAc 2-epimerase/ManNAc kinase
Biochemistry
50
8914-8925
2011
Homo sapiens (Q9Y223)
brenda
Yardeni, T.; Jacobs, K.; Niethamer, T.K.; Ciccone, C.; Anikster, Y.; Kurochkina, N.; Gahl, W.A.; Huizing, M.
Murine isoforms of UDP-GlcNAc 2-epimerase/ManNAc kinase: secondary structures, expression profiles, and response to ManNAc therapy
Glycoconj. J.
30
609-618
2013
Mus musculus (Q3UW64), Mus musculus (Q91WG8), Mus musculus C57/BL6J (Q3UW64), Mus musculus C57/BL6J (Q91WG8)
brenda
Grover, S.; Arya, R.
Role of UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase (GNE) in beta1-integrin-mediated cell adhesion
Mol. Neurobiol.
50
257-273
2014
Homo sapiens
brenda
Ko, T.P.; Lai, S.J.; Hsieh, T.J.; Yang, C.S.; Chen, Y.
The tetrameric structure of sialic-acid-synthesizing UDP-GlcNAc 2-epimerase from Acinetobacter baumannii a comparative study with human GNE
J. Biol. Chem.
293
10119-10127
2018
Homo sapiens (Q9Y223), Homo sapiens
brenda
Grover, S.; Arya, R.
Role of UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase (GNE) in beta-integrin-mediated cell adhesion
Mol. Neurobiol.
50
257-273
2014
Homo sapiens (Q9Y223)
brenda
Harazi, A.; Becker-Cohen, M.; Zer, H.; Moshel, O.; Hinderlich, S.; Mitrani-Rosenbaum, S.
The interaction of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) and alpha-actinin 2 is altered in GNE myopathy M743T mutant
Mol. Neurobiol.
54
2928-2938
2017
Homo sapiens (Q9Y223)
brenda
Liu, N.; Wang, Z.K.; Wang, H.X.; Li, Y.; Niu, Z.H.; Yu, X.F.
Muscle biopsy and UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene mutation analysis in two Chinese patients with distal myopathy with rimmed vacuoles
NeuroReport
26
598-601
2015
Homo sapiens (Q9Y223)
brenda
Chen, S.C.; Huang, C.H.; Lai, S.J.; Yang, C.S.; Hsiao, T.H.; Lin, C.H.; Fu, P.K.; Ko, T.P.; Chen, Y.
Mechanism and inhibition of human UDP-GlcNAc 2-epimerase, the key enzyme in sialic acid biosynthesis
Sci. Rep.
6
23274
2016
Homo sapiens (Q9Y223)
brenda
Cerino, M.; Gorokhova, S.; Behin, A.; Urtizberea, J.A.; Kergourlay, V.; Salvo, E.; Bernard, R.; Levy, N.; Bartoli, M.; Krahn, M.
Novel pathogenic variants in a french cohort widen the mutational spectrum of GNE myopathy
J. Neuromuscul. Dis.
2
131-136
2015
Homo sapiens (Q9Y223)
brenda